Suchergebnisse - "Stagno, Fabio"

PubPharm (48)

1

The Italian Multicentric Randomized OPTkIMA Trial on Fixed vs Progressive Intermittent TKI Therapy in CML Elderly Patients : 3-Years of Molecular Response and Quality of Life Monitoring After Completing the Treatment Plan

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Malagola, M. | Iurlo, A. | Bucelli, C. | +27

2

The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib

enthalten in: Annals of hematology | 2024

von Mulas, O. | Abruzzese, E. | Luciano, L. | +26

3

Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic-phase chronic myeloid leukemia : A study from the Registro Italiano LMC and Campus CML

enthalten in: Cancer | 2023

von Tiribelli, M. | Latagliata, R. | Breccia, M. | +38

4

Long term follow-up of frontline Dasatinib in older patients with chronic myeloid leukemia in chronic phase treated outside clinical trials : a real-life cohort observational study

enthalten in: Acta oncologica (Stockholm, Sweden) | 2021

von Stagno, F. | Breccia, M. | Annunziata, M. | +24

5

Next-generation sequencing improves BCR-ABL1 mutation detection in Philadelphia chromosome-positive acute lymphoblastic leukaemia

enthalten in: British journal of haematology | 2021

von Soverini, S. | Martelli, M. | Bavaro, L. | +23

6

Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs : First interim analysis of OPTkIMA study

enthalten in: Cancer medicine | 2021

von Malagola, M. | Iurlo, A. | Abruzzese, E. | +29

ErratumIn: Cancer Med. 2021 May 2;:. - PMID 33934555

7

On the road to treatment-free remission in chronic myeloid leukemia : what about 'the others'?

enthalten in: Expert review of anticancer therapy | 2020

von Stagno, F. | Breccia, M. | Di Raimondo, F.

8

Second-line Dasatinib Therapy Improved Compliance and Deep Molecular Responses in Imatinib-intolerant Chronic Myeloid Leukemia Patients

enthalten in: Anticancer research | 2020

von Markovic, U. | Bulla, A. | Leotta, S. | +6

9

Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey

enthalten in: Leukemia | 2020

von Breccia, M. | Abruzzese, E. | Bocchia, M. | +50

10

Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors

enthalten in: Annals of hematology | 2020

von Mulas, O. | Caocci, G. | Stagno, F. | +36

1
2
3
4
5
Nächster »
[5]